Mengenai Doktor
Dr. Shigenobu Suzuki adalah antara pakar kanser mata terkemuka di Tokyo, Jepun.
Dr. Shigenobu Suzuki dikaitkan dengan Hospital Pusat Kanser Kebangsaan, Jepun.
The Department of Ocular Oncology is one of the rare groups specializing in ocular tumors, especially intraocular tumors. Recently, more than 70% of patients nationwide with retinoblastoma, which is the most frequent intraocular malignancy in childhood, and more than 50% of patients with choroidal melanoma, which is the most frequent primary intraocular malignancy in adults, have been referred to our department. We also treat ocular adnexal tumors. More than 350 operations have been done annually.
Kami mengambil bahagian dalam ujian klinikal dengan menganggarkan kejadian buruk okular kemoterapi sistemik. Terapi sasaran molekul terkini kadangkala menyebabkan edema makula, detasmen retina serous, uveitis, penyakit permukaan okular dan sebagainya, dan kami menilai dan merawat kejadian buruk ini untuk menyumbang kepada ujian klinikal.
Hospital
Pengkhususan
- Onkologi Oftalmik
Prosedur dilaksanakan
- Onkologi Oftalmik
- retinoblastoma
- Edema makula
- Koroidal melanoma
